Clozapine-Induced Myocarditis in Huntington's Disease: Case Report.

A 51-year-old male patient with Huntington's disease developed acute myocarditis during clozapine treatment initiated for psychotic symptoms.

• The patient was a 51-year-old male with an established diagnosis of Huntington's disease.
• Clozapine was initiated specifically to manage psychotic symptoms arising in the context of HD.
• The case represents a rare intersection of clozapine-induced myocarditis occurring in a neurodegenerative disease context.
• Following the discontinuation of clozapine, the patient was referred for cardiological monitoring.

Clozapine-induced myocarditis is a severe complication that typically emerges within the first weeks of treatment and can lead to cardiovascular collapse if not recognized early.

• Clozapine administration has been associated with rare but potentially fatal adverse effects, including agranulocytosis and myocarditis.
• The complication is described as 'rare but potentially life-threatening.'
• Early recognition is emphasized as critical to preventing cardiovascular collapse.
• The paper discusses the diagnostic process of myocarditis as a key clinical challenge.

Huntington's disease may represent an additional risk factor for clozapine-induced cardiac complications due to pre-existing cardiac vulnerability from mutant huntingtin protein accumulation.

• Cardiac autonomic dysregulation and basal cardiac stress induced by mutant huntingtin (mHTT) protein accumulation are recognized in patients with HD.
• Data regarding clozapine toxicity within the specific context of HD remain limited.
• The paper identifies the combination of HD-related cardiac stress and clozapine use as a potential contributing factor to myocarditis development.
• The authors discuss potential contributing factors to the myocarditis presentation in this neurodegenerative context.

Psychosis is a relatively rare manifestation of Huntington's disease, and clozapine may be used in this setting due to its low extrapyramidal side effect profile.

• Common psychiatric manifestations of HD include mood and anxiety disorders as well as behavioral and personality changes.
• Psychosis is described as 'relatively rare' among HD psychiatric symptoms.
• Clozapine's low extrapyramidal side effect profile makes it a treatment consideration for HD patients with psychosis.
• HD is characterized primarily by motor dysfunction, cognitive decline, and a broad spectrum of neuropsychiatric symptoms.

Early cardiac monitoring during clozapine use is highlighted as vitally important, particularly in psychiatric conditions accompanied by neurodegenerative processes.

• The case highlights 'the vital importance of early cardiac monitoring during clozapine use, particularly in psychiatric conditions accompanied by neurodegenerative processes.'
• The authors emphasize this recommendation specifically for neurodegenerative disease contexts.
• The paper's conclusion frames cardiac monitoring as a critical clinical practice implication of this case.
• The case is presented to raise awareness of this rare but potentially life-threatening complication in a vulnerable patient population.